Hospitals need to inform about brain dead patients: Maha govtDeccan HeraldMaharashtra Government today decided to make it mandatory for hospitals to inform organ transplant centres through divisional transplant co-ordination committees about brain dead…
TCTMDRenal Denervation Shows Promise for Heart Failure, Ongoing Success Against …TCTMDBoth involved the Symplicity catheter system (Medtronic, Minneapolis, MN), with one looking at its use in heart failure and the other updating a randomized trial on…
A "mishap" at the University of Toledo Medical Center has shut down the entire donor transplant program.
Genzyme Corp. has recalled nine lots of thymoglobulin, a medication designed to treat acute kidney transplant rejection,…
Genzyme recalls some kidney transplant drugsBoston HeraldGenzyme Corp. has recalled nine lots of thymoglobulin, a medication designed to treat acute kidney transplant rejection, according to the U.S. Food and Drug Administration. The recall was initiat…
A tiny heart pump that maintains blood flow in babies and small children with serious heart failure proved effective and life-saving in a pioneering study involving 17 institutions led by Texas Childr
Robin Roberts has announced that Friday will be her last day on “Good Morning America,” before she begins medical leave to treat the blood and bone marrow disease myelodysplastic syndrome (MDS).
Genzyme Corp. has recalled several lots of the transplant anti-rejection drug thymoglobulin, after one lot failed a periodic stability test.
Ivabradine May Reduce HF ReadmissionsMedPage TodayIvabradine (Procoralan) added to standard heart failure therapy reduced HF readmissions by a third in patients with systolic heart failure compared with patients on standard treatment, according to a po…
Genzyme recalls transplant drugMass High TechThymoglobulin is given to kidney transplant patients to treat acute rejection of the organ, and is given in conjunction with immunosuppression therapy. The recall was launched on August 2, and the affected l…